AJANTA PHARMA
Back to Cashflow Statement
|
AJANTA PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹529 Cr | ₹1,157 Cr | ₹785 Cr | ₹792 Cr | ₹562 Cr |
What is the latest Cash Flow from Operating Activities ratio of AJANTA PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹529 Cr |
| Mar2025 | ₹1,157 Cr |
| Mar2024 | ₹785 Cr |
| Mar2023 | ₹792 Cr |
| Mar2022 | ₹562 Cr |
How is Cash Flow from Operating Activities of AJANTA PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹529 Cr | -54.27 | |
| Mar2025 | ₹1,157 Cr | 47.40 | |
| Mar2024 | ₹785 Cr | -0.89 | |
| Mar2023 | ₹792 Cr | 41.02 | |
| Mar2022 | ₹562 Cr | - | |
Compare Cash Flow from Operating Activities of peers of AJANTA PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJANTA PHARMA | ₹45,504.4 Cr | -2% | 5.8% | 36.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,090.0 Cr | 1% | -2.7% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,976.0 Cr | 0.7% | 17.1% | 40.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,639.0 Cr | -0.3% | -3.7% | 37.9% | Stock Analytics | |
| CIPLA | ₹115,216.0 Cr | -0.3% | 2.3% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.4 Cr | -1.4% | 0.7% | -6.2% | Stock Analytics | |
AJANTA PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJANTA PHARMA | -2% |
5.8% |
36.6% |
| SENSEX | -0.6% |
1% |
-3.7% |
You may also like the below Video Courses